Our goal is to improve human health by diagnosing, treating and preventing disease by affecting the human microbiome.
Key elements to achieve this goal are to:
- Explore the potential of the microbiome-body connection to create a differentiated product portfolio. We believe the microbiome has the potential to impact across a range of disease areas and we are committed to pursuing many opportunities in which our platform has the potential to transform the treatment of a broad range of diseases. Our main focus areas include oncology, respiratory diseases, diabetology (with GDM) and gastroenterology.
- Commercialize our solutions to advance and scale our platform. We plan to continue to invest in our research across multiple focus areas. Our manufacturing processes are designed to ensure the quality and scalability of our products. We plan to continue to invest in novel methods for process development, manufacturing and formulation for our microbiome-based therapeutics. We plan to leverage the efficiency of our integrated capabilities to accelerate the clinical development of many product candidates.
- Adequately protect our intellectual property to secure our technology and products. We intend to diligently pursue patent protection for our scientific innovations and to maintain a strong and broad estate of patents and trade secrets in Europe. In addition to patents, we rely on trade secrets and know-how to develop and maintain our competitive position. We protect trade secrets and know-how by establishing confidentiality agreements and intellectual property assignment agreements with our employees, consultants, scientific advisors, contractors and collaborators. In addition, we take other appropriate precautions, such as physical and technological security measures, to guard against misappropriation of our proprietary information by third parties.
- Actively collaborate to realize the potential of the microbiome. We intend to continue to seek collaborations with Universities, biotech and pharmaceutical companies to realize the value of our broad research and extend the range of our development activities in a timely and cost-effective manner. We plan to commercialize products on our own as well as with valuable collaborators.